Thirty eight patients aged over 60 with end stage renal disease were treated by continuous ambulatory peritoneal dialysis for up to three years. Most of these patients, because of their age or coexisting diseases, had been considered to be unsuitable for heamodialysis by the criteria used before the advent of continuous ambulatory peritoneal dialysis in 1980. Actuarial patient survival at one and two years was 72% and 61% respectively, and only two patients were permanently transferred to haemodialysis. Twenty one of the 23 survivors were fully rehabilitated, the remaining two being partially disabled but living at home.
Introduction
Few patients over 60 years old started dialysis in Britain until 1980, when the use of continuous ambulatory peritoneal dialysis became widespread." Indeed, the major reason for Britain's poor record in treating renal failure compared with other western European countries has been the fact that until recently only a small proportion of patients with renal failure aged 45-55 and virtually none aged over 55 had been treated.2 Underlying this is the strategy of provision of renal replacement services in Britain, home haemodialysis and transplantation being the favoured modes of treatment. In contrast, hospital haemodialysis is the commonest form of treatment for renal failure in the rest of western Europe. 3 With the scarcity of permanent beds for hospital haemodialysis in Britain there has been a reluctance to accept older patients with renal failure for treatment as these patients are often, for various reasons, unsuitable for home haemodialysis and would in the past rapidly have filled the limited number of beds for dialysis. With the advent of continuous ambulatory peritoneal dialysis, however, there has been a rapid and radical change in the upper age limit of patients accepted for renal replacement treatment in Britain-that is to say, most nephrologists are now prescribing continuous ambulatory peritoneal dialysis to older patients who, some years ago, would not have received any treatment at all (and would thus, have been left to die), as they would not have been suitable for home haemodialysis and could not, for lack of resources, be accommodated on hospital haemodialysis programmes. of this policy. It Peritonitis-The overall incidence of peritonitis after discharge from hospital after initial inpatient training was one episode per 12-5 patient months. Fifteen per cent of these episodes were due to cracked or leaking peritoneal dialysis catheters, which were subse-quently removed and replaced after a period of haemodialysis. Only one death was due to peritonitis, probably of bowel origin (see above).
Drop outs-Apart from the 11 patients who died, two had to stop using continuous ambulatory peritoneal dialysis and were successfully transferred to haemodialysis. One, who developed peritonitis due to diverticulitis, subsequently received home haemodialysis; the other, who had a single unresolved episode of peritonitis that necessitated removal of the catheter, changed to permanent hospital haemodialysis, which she preferred. 
Discussion
Our initial three year experience with a relatively large number of elderly patients receiving continuous ambulatory peritoneal dialysis is highly encouraging. The overall survival of this largely unselected group of patients, who often had coexisting heart and lung disease, is similar to European figures for survival of patients over 55 years old receiving haemodialysis.3 In general, patients either survive and do well with continuous ambulatory peritoneal dialysis or die soon after starting treatment. We have not created a pool of dissatisfied patients who are kept alive by continuous ambulatory peritoneal dialysis merely to suffer from other diseases, nor have we overburdened our limited hospital haemodialysis facilities.
The impact of continuous ambulatory peritoneal dialysis on our provision of renal replacement treatment has been enormous. The number of new patients entering our programme has risen by roughly half, and this is almost entirely due to the influx of patients over 60 years old (though we have also been more liberal in treating younger diabetics). The current rate of acceptance of new patients of around 30 patients per million population per year, however, is still far below that found in most other countries, so our experience is the same as that of other units who honestly claim to treat almost every patient that is referred to them in the knowledge that many more die without ever being referred.5 6 On the basis of our experience we believe that there are no medical grounds for denying continuous ambulatory peritoneal dialysis to most elderly patients with renal failure. MASTICH stays fluxes, being taken inwardly any way. Three or four small grains of Mastich, swallowed at night going to bed, is a remedy for pains in the stomach: being beaten into powder, and mixed with conserve of Roses, it strengthens the stomach, stops distillations upon the lungs, stays vomiting, and causes a sweet breath; being mixed with white wine and .the mouth it taken at a time helps rheumatic distillations upon the lungs, pains in the sides; it stops fluxes, provokes the menses, brings away both birth and after-birth, softens the hardness of the womb; being taken two hours before the fit comes, it helps agues. MATHIOLUS saith he seldom used any other medicine for the quartan ague than a dram of myrrh given in Muskadel an hour before the fit usually came; if you make it up into pills with treacle, and take one of them every morning fasting, it is a sovereign preservative against the pestilence, against the poison of serpents, and other venomous beasts; a singular remedy for a stinking breath if it arise from putrefaction of the stomach, it fastens loose teeth, and stays the shedding off of the hair, outwardly used it breeds flesh in dee.p wounds, and covers the naked bones with flesh. (Nicholas Culpeper (1616-54) The Complete Herbal, 1850.)
